免疫检查点
医学
癌症研究
放射性核素治疗
免疫系统
靶向治疗
免疫疗法
封锁
免疫学
肿瘤科
核医学
癌症
内科学
受体
作者
Ravi B. Patel,Reinier Hernandez,Peter M. Carlson,Joseph Grudzinski,Amber M. Bates,Justin C. Jagodinsky,Amy K. Erbe,Ian Marsh,Ian S. Arthur,Eduardo Aluicio‐Sarduy,Raghava N. Sriramaneni,Won Jong Jin,Christopher Massey,Alexander L. Rakhmilevich,David M. Vail,Jonathan W. Engle,Trаng Lе,KyungMann Kim,Bryan Bednarz,Paul M. Sondel,Jamey P. Weichert,Zachary S. Morris
出处
期刊:Science Translational Medicine
[American Association for the Advancement of Science (AAAS)]
日期:2021-07-14
卷期号:13 (602)
被引量:124
标识
DOI:10.1126/scitranslmed.abb3631
摘要
Low-dose targeted radionuclide therapy combined with immune checkpoint inhibition enhances complete response rates in preclinical tumor models.
科研通智能强力驱动
Strongly Powered by AbleSci AI